ID I5P1_HUMAN Reviewed; 412 AA. AC Q14642; D3DXI3; Q14640; Q5JSF1; DT 15-JUL-1998, integrated into UniProtKB/Swiss-Prot. DT 01-NOV-1996, sequence version 1. DT 24-JAN-2024, entry version 178. DE RecName: Full=Inositol polyphosphate-5-phosphatase A; DE EC=3.1.3.56 {ECO:0000269|PubMed:8013665, ECO:0000269|PubMed:8626616, ECO:0000269|PubMed:8769125}; DE AltName: Full=43 kDa inositol polyphosphate 5-phosphatase {ECO:0000303|PubMed:8006039}; DE AltName: Full=Type I inositol 1,4,5-trisphosphate 5-phosphatase {ECO:0000303|PubMed:8013665}; DE Short=5PTase {ECO:0000303|PubMed:8013665}; DE Flags: Precursor; GN Name=INPP5A {ECO:0000312|HGNC:HGNC:6076}; GN Synonyms=5PTASE {ECO:0000303|PubMed:8013665}; OS Homo sapiens (Human). OC Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia; OC Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae; OC Homo. OX NCBI_TaxID=9606; RN [1] RP NUCLEOTIDE SEQUENCE [MRNA], FUNCTION, TISSUE SPECIFICITY, AND CATALYTIC RP ACTIVITY. RC TISSUE=Brain; RX PubMed=8013665; DOI=10.1016/0014-5793(94)00509-5; RA de Smedt F., Verjans B., Mailleux P., Erneux C.; RT "Cloning and expression of human brain type I inositol 1,4,5-trisphosphate RT 5-phosphatase. High levels of mRNA in cerebellar Purkinje cells."; RL FEBS Lett. 347:69-72(1994). RN [2] RP NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]. RX PubMed=15164054; DOI=10.1038/nature02462; RA Deloukas P., Earthrowl M.E., Grafham D.V., Rubenfield M., French L., RA Steward C.A., Sims S.K., Jones M.C., Searle S., Scott C., Howe K., RA Hunt S.E., Andrews T.D., Gilbert J.G.R., Swarbreck D., Ashurst J.L., RA Taylor A., Battles J., Bird C.P., Ainscough R., Almeida J.P., RA Ashwell R.I.S., Ambrose K.D., Babbage A.K., Bagguley C.L., Bailey J., RA Banerjee R., Bates K., Beasley H., Bray-Allen S., Brown A.J., Brown J.Y., RA Burford D.C., Burrill W., Burton J., Cahill P., Camire D., Carter N.P., RA Chapman J.C., Clark S.Y., Clarke G., Clee C.M., Clegg S., Corby N., RA Coulson A., Dhami P., Dutta I., Dunn M., Faulkner L., Frankish A., RA Frankland J.A., Garner P., Garnett J., Gribble S., Griffiths C., RA Grocock R., Gustafson E., Hammond S., Harley J.L., Hart E., Heath P.D., RA Ho T.P., Hopkins B., Horne J., Howden P.J., Huckle E., Hynds C., RA Johnson C., Johnson D., Kana A., Kay M., Kimberley A.M., Kershaw J.K., RA Kokkinaki M., Laird G.K., Lawlor S., Lee H.M., Leongamornlert D.A., RA Laird G., Lloyd C., Lloyd D.M., Loveland J., Lovell J., McLaren S., RA McLay K.E., McMurray A., Mashreghi-Mohammadi M., Matthews L., Milne S., RA Nickerson T., Nguyen M., Overton-Larty E., Palmer S.A., Pearce A.V., RA Peck A.I., Pelan S., Phillimore B., Porter K., Rice C.M., Rogosin A., RA Ross M.T., Sarafidou T., Sehra H.K., Shownkeen R., Skuce C.D., Smith M., RA Standring L., Sycamore N., Tester J., Thorpe A., Torcasso W., Tracey A., RA Tromans A., Tsolas J., Wall M., Walsh J., Wang H., Weinstock K., West A.P., RA Willey D.L., Whitehead S.L., Wilming L., Wray P.W., Young L., Chen Y., RA Lovering R.C., Moschonas N.K., Siebert R., Fechtel K., Bentley D., RA Durbin R.M., Hubbard T., Doucette-Stamm L., Beck S., Smith D.R., Rogers J.; RT "The DNA sequence and comparative analysis of human chromosome 10."; RL Nature 429:375-381(2004). RN [3] RP NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]. RA Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L., Mobarry C.M., RA Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R., Flanigan M.J., RA Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V., Hannenhalli S., RA Turner R., Yooseph S., Lu F., Nusskern D.R., Shue B.C., Zheng X.H., RA Zhong F., Delcher A.L., Huson D.H., Kravitz S.A., Mouchard L., Reinert K., RA Remington K.A., Clark A.G., Waterman M.S., Eichler E.E., Adams M.D., RA Hunkapiller M.W., Myers E.W., Venter J.C.; RL Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases. RN [4] RP NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA]. RX PubMed=15489334; DOI=10.1101/gr.2596504; RG The MGC Project Team; RT "The status, quality, and expansion of the NIH full-length cDNA project: RT the Mammalian Gene Collection (MGC)."; RL Genome Res. 14:2121-2127(2004). RN [5] RP NUCLEOTIDE SEQUENCE [MRNA] OF 49-412, TISSUE SPECIFICITY, AND SUBCELLULAR RP LOCATION. RC TISSUE=Placenta; RX PubMed=8006039; DOI=10.1016/s0021-9258(17)32555-3; RA Laxminarayan K.M., Chan B.K., Tetaz T., Bird P.I., Mitchell C.A.; RT "Characterization of a cDNA encoding the 43-kDa membrane-associated RT inositol-polyphosphate 5-phosphatase."; RL J. Biol. Chem. 269:17305-17310(1994). RN [6] RP CATALYTIC ACTIVITY, AND FUNCTION. RX PubMed=8769125; DOI=10.1006/bbrc.1996.1161; RA Drayer A.L., Pesesse X., De Smedt F., Woscholski R., Parker P., Erneux C.; RT "Cloning and expression of a human placenta inositol 1,3,4,5- RT tetrakisphosphate and phosphatidylinositol 3,4,5-trisphosphate 5- RT phosphatase."; RL Biochem. Biophys. Res. Commun. 225:243-249(1996). RN [7] RP FUNCTION, CATALYTIC ACTIVITY, SUBCELLULAR LOCATION, ISOPRENYLATION AT RP CYS-409, AND MUTAGENESIS OF 408-CYS--GLN-412 AND CYS-409. RX PubMed=8626616; DOI=10.1074/jbc.271.17.10419; RA De Smedt F., Boom A., Pesesse X., Schiffmann S.N., Erneux C.; RT "Post-translational modification of human brain type I inositol-1,4,5- RT trisphosphate 5-phosphatase by farnesylation."; RL J. Biol. Chem. 271:10419-10424(1996). CC -!- FUNCTION: Phosphatase that specifically hydrolyzes the 5-phosphate of CC inositol 1,4,5-trisphosphate to inositol 1,4-bisphosphate, and inositol CC 1,3,4,5-tetrasphosphate to inositol 1,3,4-trisphosphate CC (PubMed:8013665, PubMed:8769125, PubMed:8626616). Plays a crucial role CC in the survival of cerebellar Purkinje cells (By similarity). CC {ECO:0000250|UniProtKB:Q7TNC9, ECO:0000269|PubMed:8013665, CC ECO:0000269|PubMed:8626616, ECO:0000269|PubMed:8769125}. CC -!- CATALYTIC ACTIVITY: CC Reaction=1D-myo-inositol 1,4,5-trisphosphate + H2O = 1D-myo-inositol CC 1,4-bisphosphate + phosphate; Xref=Rhea:RHEA:19797, CC ChEBI:CHEBI:15377, ChEBI:CHEBI:43474, ChEBI:CHEBI:58282, CC ChEBI:CHEBI:203600; EC=3.1.3.56; CC Evidence={ECO:0000269|PubMed:8013665, ECO:0000269|PubMed:8626616, CC ECO:0000269|PubMed:8769125}; CC PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:19798; CC Evidence={ECO:0000305|PubMed:8769125}; CC -!- CATALYTIC ACTIVITY: CC Reaction=1D-myo-inositol 1,3,4,5-tetrakisphosphate + H2O = 1D-myo- CC inositol 1,3,4-trisphosphate + phosphate; Xref=Rhea:RHEA:11392, CC ChEBI:CHEBI:15377, ChEBI:CHEBI:43474, ChEBI:CHEBI:57895, CC ChEBI:CHEBI:58414; EC=3.1.3.56; Evidence={ECO:0000269|PubMed:8626616, CC ECO:0000269|PubMed:8769125}; CC PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:11393; CC Evidence={ECO:0000305|PubMed:8769125}; CC -!- SUBUNIT: Interacts with TASOR. {ECO:0000250|UniProtKB:Q7TNC9}. CC -!- INTERACTION: CC Q14642; P08567: PLEK; NbExp=4; IntAct=EBI-8670520, EBI-2565501; CC Q14642; Q15562-2: TEAD2; NbExp=3; IntAct=EBI-8670520, EBI-9370956; CC -!- SUBCELLULAR LOCATION: Cell membrane {ECO:0000269|PubMed:8626616, CC ECO:0000305|PubMed:8006039}; Lipid-anchor {ECO:0000269|PubMed:8626616, CC ECO:0000305}. Cell projection, dendrite {ECO:0000250|UniProtKB:Q7TNC9}. CC -!- TISSUE SPECIFICITY: Predominantly expressed in heart, brain, and CC skeletal muscle (PubMed:8006039). In brain; high level in Purkinje CC cells (PubMed:8013665). {ECO:0000269|PubMed:8006039, CC ECO:0000269|PubMed:8013665}. CC -!- PTM: Isoprenylation at Cys-409 is required for localization at the CC membrane. {ECO:0000269|PubMed:8626616}. CC -!- SIMILARITY: Belongs to the inositol 1,4,5-trisphosphate 5-phosphatase CC type I family. {ECO:0000305}. CC --------------------------------------------------------------------------- CC Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms CC Distributed under the Creative Commons Attribution (CC BY 4.0) License CC --------------------------------------------------------------------------- DR EMBL; X77567; CAA54676.1; -; mRNA. DR EMBL; AL392043; -; NOT_ANNOTATED_CDS; Genomic_DNA. DR EMBL; AL451069; -; NOT_ANNOTATED_CDS; Genomic_DNA. DR EMBL; AL356603; -; NOT_ANNOTATED_CDS; Genomic_DNA. DR EMBL; CH471211; EAW61306.1; -; Genomic_DNA. DR EMBL; CH471211; EAW61307.1; -; Genomic_DNA. DR EMBL; BC096280; AAH96280.1; -; mRNA. DR EMBL; Z31695; CAA83500.1; -; mRNA. DR CCDS; CCDS7669.2; -. DR PIR; S45721; S45721. DR RefSeq; NP_001307971.1; NM_001321042.1. DR RefSeq; NP_005530.3; NM_005539.4. DR AlphaFoldDB; Q14642; -. DR BioGRID; 109844; 35. DR IntAct; Q14642; 15. DR MINT; Q14642; -. DR STRING; 9606.ENSP00000357583; -. DR BindingDB; Q14642; -. DR ChEMBL; CHEMBL4243; -. DR GuidetoPHARMACOLOGY; 1453; -. DR SwissLipids; SLP:000000952; -. DR DEPOD; INPP5A; -. DR iPTMnet; Q14642; -. DR PhosphoSitePlus; Q14642; -. DR SwissPalm; Q14642; -. DR BioMuta; INPP5A; -. DR DMDM; 3122245; -. DR EPD; Q14642; -. DR jPOST; Q14642; -. DR MassIVE; Q14642; -. DR MaxQB; Q14642; -. DR PaxDb; 9606-ENSP00000357583; -. DR PeptideAtlas; Q14642; -. DR ProteomicsDB; 60080; -. DR Pumba; Q14642; -. DR Antibodypedia; 1413; 185 antibodies from 25 providers. DR DNASU; 3632; -. DR Ensembl; ENST00000368594.8; ENSP00000357583.3; ENSG00000068383.19. DR GeneID; 3632; -. DR KEGG; hsa:3632; -. DR MANE-Select; ENST00000368594.8; ENSP00000357583.3; NM_005539.5; NP_005530.3. DR UCSC; uc001llp.4; human. DR AGR; HGNC:6076; -. DR CTD; 3632; -. DR DisGeNET; 3632; -. DR GeneCards; INPP5A; -. DR HGNC; HGNC:6076; INPP5A. DR HPA; ENSG00000068383; Low tissue specificity. DR MIM; 600106; gene. DR neXtProt; NX_Q14642; -. DR OpenTargets; ENSG00000068383; -. DR PharmGKB; PA29884; -. DR VEuPathDB; HostDB:ENSG00000068383; -. DR eggNOG; KOG1976; Eukaryota. DR GeneTree; ENSGT00390000015226; -. DR InParanoid; Q14642; -. DR OMA; GDHKPVM; -. DR OrthoDB; 2898734at2759; -. DR PhylomeDB; Q14642; -. DR TreeFam; TF314246; -. DR BioCyc; MetaCyc:HS00936-MONOMER; -. DR BRENDA; 3.1.3.56; 2681. DR PathwayCommons; Q14642; -. DR Reactome; R-HSA-1855183; Synthesis of IP2, IP, and Ins in the cytosol. DR SignaLink; Q14642; -. DR BioGRID-ORCS; 3632; 20 hits in 1168 CRISPR screens. DR ChiTaRS; INPP5A; human. DR GeneWiki; INPP5A; -. DR GenomeRNAi; 3632; -. DR Pharos; Q14642; Tchem. DR PRO; PR:Q14642; -. DR Proteomes; UP000005640; Chromosome 10. DR RNAct; Q14642; Protein. DR Bgee; ENSG00000068383; Expressed in lateral nuclear group of thalamus and 212 other cell types or tissues. DR ExpressionAtlas; Q14642; baseline and differential. DR GO; GO:0030425; C:dendrite; ISS:UniProtKB. DR GO; GO:0016020; C:membrane; IDA:MGI. DR GO; GO:0005886; C:plasma membrane; IDA:UniProtKB. DR GO; GO:0052659; F:inositol-1,3,4,5-tetrakisphosphate 5-phosphatase activity; IEA:UniProtKB-EC. DR GO; GO:0052658; F:inositol-1,4,5-trisphosphate 5-phosphatase activity; TAS:Reactome. DR GO; GO:0004445; F:inositol-polyphosphate 5-phosphatase activity; IDA:UniProtKB. DR GO; GO:0042731; F:PH domain binding; IPI:BHF-UCL. DR GO; GO:0043647; P:inositol phosphate metabolic process; TAS:Reactome. DR GO; GO:1900737; P:negative regulation of phospholipase C-activating G protein-coupled receptor signaling pathway; ISS:UniProtKB. DR GO; GO:0046856; P:phosphatidylinositol dephosphorylation; IEA:InterPro. DR CDD; cd09092; INPP5A; 1. DR Gene3D; 3.60.10.10; Endonuclease/exonuclease/phosphatase; 1. DR InterPro; IPR036691; Endo/exonu/phosph_ase_sf. DR InterPro; IPR039737; INPP5A. DR InterPro; IPR000300; IPPc. DR PANTHER; PTHR12997:SF2; INOSITOL POLYPHOSPHATE-5-PHOSPHATASE A; 1. DR PANTHER; PTHR12997; TYPE I INOSITOL-1,4,5-TRISPHOSPHATE 5-PHOSPHATASE; 1. DR SMART; SM00128; IPPc; 1. DR SUPFAM; SSF56219; DNase I-like; 1. DR Genevisible; Q14642; HS. PE 1: Evidence at protein level; KW Cell membrane; Cell projection; Hydrolase; Lipoprotein; Membrane; KW Prenylation; Reference proteome. FT CHAIN 1..409 FT /note="Inositol polyphosphate-5-phosphatase A" FT /id="PRO_0000209719" FT PROPEP 410..412 FT /note="Removed in mature form" FT /evidence="ECO:0000269|PubMed:8626616" FT /id="PRO_0000396780" FT LIPID 409 FT /note="S-farnesyl cysteine" FT /evidence="ECO:0000269|PubMed:8626616" FT VARIANT 45 FT /note="K -> R (in dbSNP:rs1133400)" FT /id="VAR_034006" FT MUTAGEN 408..412 FT /note="Missing: Loss of membrane localization. No loss of FT enzyme activity." FT /evidence="ECO:0000269|PubMed:8626616" FT MUTAGEN 409 FT /note="C->S: Loss of prenylation and membrane localization. FT No loss of enzyme activity." FT /evidence="ECO:0000269|PubMed:8626616" FT CONFLICT 152..172 FT /note="PQDYFPECKWSRKGFIRTRWC -> RRLLPRVQMVKKRLHPDEVV (in FT Ref. 5; CAA83500)" FT /evidence="ECO:0000305" FT CONFLICT 247..251 FT /note="CTKAT -> SAKPP (in Ref. 5; CAA83500)" FT /evidence="ECO:0000305" SQ SEQUENCE 412 AA; 47820 MW; F55C0DFDDA01A850 CRC64; MAGKAAAPGT AVLLVTANVG SLFDDPENLQ KNWLREFYQV VHTHKPHFMA LHCQEFGGKN YEASMSHVDK FVKELLSSDA MKEYNRARVY LDENYKSQEH FTALGSFYFL HESLKNIYQF DFKAKKYRKV AGKEIYSDTL ESTPMLEKEK FPQDYFPECK WSRKGFIRTR WCIADCAFDL VNIHLFHDAS NLVAWETSPS VYSGIRHKAL GYVLDRIIDQ RFEKVSYFVF GDFNFRLDSK SVVETLCTKA TMQTVRAADT NEVVKLIFRE SDNDRKVMLQ LEKKLFDYFN QEVFRDNNGT ALLEFDKELS VFKDRLYELD ISFPPSYPYS EDARQGEQYM NTRCPAWCDR ILMSPSAKEL VLRSESEEKV VTYDHIGPNV CMGDHKPVFL AFRIMPGAGK PHAHVHKCCV VQ //